Women's Health
Hypothyroidism more prevalent during late perimenopause, postmenopause
The prevalence of hypothyroidism — overt and subclinical — is higher among women during the late menopause transition and postmenopause compared with premenopause, according to study findings.
Safety-net hospital sees increase in late-stage breast cancer diagnoses during pandemic
COVID-19 restrictions led to a 1.2-fold increase in presentation of late-stage breast cancer at an urban safety-net hospital, according to a study presented at an American Society of Breast Surgeons Annual Meeting press briefing.
Sentinel lymph node biopsy may not be necessary for some older women with breast cancer
Similar proportions of older women with node-negative and node-positive early breast cancer had Oncotype Dx breast recurrence scores that would qualify them for adjuvant chemotherapy, according to study results.
Molecular differences may explain higher breast cancer mortality rates among Black women
Black women are 41% more likely to die of breast cancer than white women, according to American Cancer Society statistics.
Roundtables aim to improve outcomes for, reduce disparities in breast, cervical cancers
Arif Kamal, MD, MBA, MHS, chief patient officer at American Cancer Society, spoke with Healio about two national roundtables the society will launch to drive progress against breast cancer and cervical cancer.
Rubraca extends PFS as maintenance therapy in ovarian cancer, topline data show
Rucaparib monotherapy significantly extended PFS compared with placebo as first-line maintenance treatment for women with ovarian cancer, according to topline data from the randomized phase 3 ATHENA-MONO trial.
Shift work linked to delayed onset of menopause
Women who were employed in rotating or night shift work at some point in their lives are more likely to experience delayed onset of menopause compared with women working only during the day, according to study data published in Menopause.
Atezolizumab safe before, during chemoradiation, active in women with cervical cancer
Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity among women with node-positive locally advanced cervical cancer, according to study results.
Lack of evidence supporting DHEA for improved overall health for women
Current evidence does not support dehydroepiandrosterone use to improve women’s menopausal symptoms, sexual health and overall well-being, and long-term use may lead to estrogenic adverse events, according to a review article.
MAPK mutations linked to longer survival in ovarian cancer subset
Women with mitogen-activated protein kinase-mutated low-grade serous ovarian/peritoneal carcinoma experienced significantly longer PFS and OS compared with women without these mutations, according to study results.